MENU
MNPR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Monopar Therapeutics (MNPR) Ownership - Who owns Monopar Therapeutics?
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients... Show more
Profile
Industry
N/A
Address
1000 Skokie Boulevard
Phone
+1 847 388-0349
Employees
10
Web
https://www.monopartx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
262.6M
P/E Ratio
N/A
Total Cash
6.02M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
2.01
Dividend Yield
N/A
Total Cash/Share
0.98
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
MNPR
Capitalization
263M
P/E Ratio
N/A
Risk (Beta)
2.01
Dividend Yield
N/A
Total Cash
6.02M
Total Cash/Share
0.98
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
4.95M
P/B Ratio
4.66
Cash Flow
N/A
Earnings
-1.98
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3.53K
Current Ratio
5.41
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-7M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-88.32
Shares Held By Institutions
59.3M
Shares Outstanding - Current
6.11M
Total Liabilities
1.12M
Total Volume MTD
N/A
Value
N/A
Gain YTD
90.636
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical stage biopharmaceutical company, which engages in building a drug development pipeline of oncology therapeutics in late preclinical and clinical development stages
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1000 Skokie Boulevard
Phone
+1 847 388-0349
Employees
10
Web
https://www.monopartx.com